PRP for Hand and Thumb OA: Effects on Basal Joint and STT Joint
Rydberg M · PLOS One (2022)
DOI: 10.1371/journal.pone.0264203This retrospective case series from a specialized hand surgery unit evaluated PRP injections for both thumb basal joint and scaphoidtrapeziotrapezoidal (STT) joint OA in 29 patients. Using the Arthrex ACP double-syringe system, patients received two radiologically guided PRP injections 3-4 weeks apart. Despite controlling for confounders using generalized estimating equations (GEE), PRP showed no significant effect on any objective outcome measure.
Clinical Relevance
The disconnect between subjective improvement (57%) and objective measures (no change) suggests PRP may have a strong placebo component in hand OA. Clinicians should be cautious about interpreting patient satisfaction alone as evidence of efficacy.
Key Takeaways
- No objective improvement in pain, function, or strength at 3 months
- 16/28 patients reported subjective improvement despite no objective change (placebo effect)
- Used Arthrex ACP (LP-PRP) system, well-characterized protocol
- Small injection volumes (0.5-2 mL) appropriate for small joints
- GEE analysis controlled for confounders (age, sex, occupation, pain level)
- Only 3-month follow-up (may be too short)
- STT joint OA also included (rare data for this joint)
Key Findings
29 patients (21 thumb CMC, 8 STT). GEE analysis showed PRP had NO significant effect on pain, PRWHE, grip strength, or key pinch at 3 months. 16/28 patients subjectively reported improvement despite no objective improvement. Short-term PRP effect for hand OA is doubtful.
Clinical Context
Study Design
Retrospective Case Series
Condition
Thumb Basal Joint OA and Scaphoidtrapeziotrapezoidal (STT) Joint OA
Sample Size
29 patients
Follow-up
3 months
Control Group
None (before-after comparison)
Primary Outcome
NRS Pain, PRWHE, Grip/Pinch Strength
PRP Protocol & Intervention
Preparation System
Arthrex ACP Double-Syringe
Leukocyte Status
LP-PRP (ACP system)
Spin Protocol
1500 rpm for 5 minutes
Injection Frequency
2 injection(s)
Injection Interval
3-4 weeks
Guidance Method
Radiologically guided
